tetraallyl pyrophosphate | 7369-40-6

• 分子结构分类: 有机化合物 - 有机氧化合物 - 有机含氧阴离子化合物
• 英文名称: tetraallyl pyrophosphate
• 英文别名: diphosphoric acid tetraallyl ester；allyl pyrophosphate；Tetraallyl-pyrophosphat；Bis(prop-2-enoxy)phosphoryl bis(prop-2-enyl) phosphate；bis(prop-2-enoxy)phosphoryl bis(prop-2-enyl) phosphate
• CAS: 7369-40-6
• 化学式: C₁₂H₂₀O₇P₂
• 分子量: 338.234
• InChiKey: QJMPKPIZIMCXJI-UHFFFAOYSA-N

物化性质

• 沸点：
  316.7±42.0 °C(Predicted)
• 密度：
  1.178±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  21
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  80.3
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  2-十二烷醇 、 tetraallyl pyrophosphate 在 titanium(IV) tetrabutoxide 、 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 18.0h， 以84%的产率得到2-dodecyldiallyl phosphate
  参考文献：
  名称：

  Catalytic Lewis acid phosphorylation with pyrophosphates

  摘要：

  We report a method for the Lewis acid catalyzed phosphorylation of alcohols with pyrophosphates. Ti((OBu)-Bu-t)(4) was found to be the most effective catalyst in the phosphorylation of both primary and secondary alcohols with tetrabenzylpyrophosphate, providing conversions between 54% and >98% and isolated yields between 50% and 97%. Other pyrophosphates with orthogonal protecting groups were synthesized and screened to validate the generality of the approach. This study will describe how benzyl, methyl, ethyl, allyl, and o-nitrobenzyl pyrophosphates are all effective phosphorylating agents under Lewis acid catalysis. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2012.08.070
• 作为产物：
  描述：

  diallyl phosphate 在 N,N'-二环己基碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 4.0h， 以99.5%的产率得到tetraallyl pyrophosphate
  参考文献：
  名称：

  Catalytic Lewis acid phosphorylation with pyrophosphates

  摘要：

  We report a method for the Lewis acid catalyzed phosphorylation of alcohols with pyrophosphates. Ti((OBu)-Bu-t)(4) was found to be the most effective catalyst in the phosphorylation of both primary and secondary alcohols with tetrabenzylpyrophosphate, providing conversions between 54% and >98% and isolated yields between 50% and 97%. Other pyrophosphates with orthogonal protecting groups were synthesized and screened to validate the generality of the approach. This study will describe how benzyl, methyl, ethyl, allyl, and o-nitrobenzyl pyrophosphates are all effective phosphorylating agents under Lewis acid catalysis. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2012.08.070

文献信息

• [EN] QUINOLINES AS INHIBITORS OF FARNESYL PYROPHOSPHATE SYNTHASE<br/>[FR] QUINOLÉINES EN TANT QU'INHIBITEURS DE LA FARNÉSYL PYROPHOSPHATE SYNTHASE
  申请人：NOVARTIS AG

  公开号：WO2009106586A1

  公开（公告）日：2009-09-03

  The invention relates to a compound of formula (I) wherein the substituents are as described in the specification, which are useful as farnesyl pyrophosphate synthase modulators, e.g. in the treatment of proliferative diseases, to methods of manufacturing such compounds and to intermediates thereof.

  本发明涉及式(I)化合物，其中取代基如说明书中所述，这些化合物作为法尼基焦磷酸合酶调节剂是有用的，例如在增殖性疾病的治疗中，涉及制造这些化合物的方法及其中间体。
• [EN] SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS<br/>[FR] DÉRIVÉS D'ACIDE SALICYLIQUE EN TANT QU'INHIBITEURS DE L'ACTIVITÉ FARNÉSYLPYROPHOSPHATE SYNTHASE
  申请人：NOVARTIS AG

  公开号：WO2010043584A1

  公开（公告）日：2010-04-22

  The invention relates to the use of and mainly novel compounds of the formula (I) wherein the moieties are as defined in the description, which are useful as farnesyl pyrophosphate synthase modulators and e.g. in the treatment of proliferative diseases.

  该发明涉及使用主要是新颖化合物的公式（I），其中基团如描述中定义的，这些化合物可用作法尼基焦磷酸合酶调节剂，例如用于治疗增殖性疾病。
• SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS
  申请人：Cotesta Simona

  公开号：US20110288057A1

  公开（公告）日：2011-11-24

  The invention relates to the use of and mainly novel compounds of the formula I wherein the moieties are as defined in the description, which are useful as farnesyl pyrophosphate synthase modulators and e.g. in the treatment of proliferative diseases.

  本发明涉及使用式I中定义的基团的化合物，其中基团如描述中所定义，这些化合物可用作法尼醇焦磷酸合酶调节剂，例如用于治疗增殖性疾病。
• QUINOLINES AS INHIBITORS OF FARNESYL PYROPHOSPHATE SYNTHASE
  申请人：Amstutz Rene

  公开号：US20120094958A1

  公开（公告）日：2012-04-19

  The invention relates to a compound of formula (I) wherein the substituents are as described in the specification, which are useful as farnesyl pyrophosphate synthase modulators, e.g. in the treatment of proliferative diseases, to methods of manufacturing such compounds and to intermediates thereof.

  本发明涉及一种式为(I)的化合物，其中取代基如规范中所述，其作为法尼酰焦磷酸合酶调节剂具有用途，例如用于治疗增殖性疾病，以及制造此类化合物及其中间体的方法。
• MICROORGANISMS AND METHODS FOR PRODUCING ALKENES
  申请人：Burk Mark J.

  公开号：US20130122563A1

  公开（公告）日：2013-05-16

  The invention provides non-naturally occurring microbial organisms containing an alkene pathway having at least one exogenous nucleic acid encoding an alkene pathway enzyme expressed in a sufficient amount to convert an alcohol to an alkene. The invention additionally provides methods of using such microbial organisms to produce an alkene, by culturing a non-naturally occurring microbial organism containing an alkene pathway as described herein under conditions and for a sufficient period of time to produce an alkene.

  本发明提供了非自然存在的微生物生物体，其含有至少一种外源核酸编码的烯烃途径酶，表达量足以将醇转化为烯烃。本发明还提供了使用这种微生物生物体生产烯烃的方法，通过在适当的条件和足够的时间下培养含有如上所述的烯烃途径的非自然存在的微生物生物体，以产生烯烃。